MEMPHIS, Tenn., Oct. 29 /PRNewswire-FirstCall/ -- Smith & Nephew's Orthopaedics business announced today it has made a first-of-its-kind contribution to the Center for Orthopaedic Trauma Advancement (COTA) for fellowship and resident education grants.
COTA is the first 501 (c) (3) non-profit corporation exclusively dedicated to funding medical education for surgeons who specialize in orthopaedic trauma patient care. The organization is working to build on Smith & Nephew's contribution with additional grants from industry, as well as non-profit entities and philanthropic sources.
About Smith & Nephew
Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding planned growth in our business and in our trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.
Smith & Nephew